Table 2 Laboratory and radiological characteristics of COVID-19 positive patients at hospital admission
Characteristics | Total 215 | Group-1 Alive 129 | Group-2 Deceased 86 | p-Value (Alive vs Deceased) |
|---|---|---|---|---|
Haemoglobin, g/L | 133 (120–146) | 134 (122–148) | 129 (118–143) | 0.08 |
Neutrophil count, × 109/L | 6 (4–9) | 6 (4–8) | 7 (4–9) | 0.02 |
Lymphocyte count, × 109/L | 0.9 (0.6–1.3) | 0.9 (0.6–1.4) | 0.8 (0.5–1.2) | 0.03 |
New lymphopenia | 85 (39.5) | 49 (37.9) | 36 (41.9) | 0.57 |
Neutrophil: lymphocyte ratio | 7 (4–13) | 6 (4–11) | 9 (5–18) | 0.004 |
Platelet count, ×109/L | 217 (161–270) | 223 (162–270) | 210 (155–265) | 0.23 |
Albumin, g/L | 30 (27–34) | 31 (28–35) | 29 (26–32) | 0.01 |
Bilirubin, umol/L | 12 (8–17) | 12 (8–18) | 11 (8–16) | 0.86 |
Alanine transaminase, U/L | 27 (18–45) | 28 (18–48) | 27 (19–39) | 0.66 |
Alkaline phosphatase, U/L | 81 (63–109) | 79 (62–107) | 85.5 (65–109) | 0.35 |
C-reactive protein, mg/L | 107 (56–177) | 90 (41–164) | 123 (72–189) | 0.009 |
D-Dimer, ng/mL | 610 (297–809) | 559 (412–748) | 775 (701–848) | 0.04 |
eGFR, mL/min/1.73m2 | 67 (42–90) | 77 (56–90) | 48.5 (28–74) | < 0.001 |
Acute kidney injury (any stage) | 65 (30.2) | 25 (19.4) | 40 (46.5) | < 0.001 |
Chest X-Ray report | ||||
Suggestive of COVID-19 | 166 (79.8) | 98 (77.8) | 68 (82.9) | 0.37 |
Bilateral infiltrates | 117 (56.2) | 67 (53.2) | 50 (61) | 0.27 |
Unilateral consolidation | 48 (23.1) | 31 (24) | 17 (19.8) | 0.46 |